Global Life Sciences IT Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Life science IT plays a crucial role in life sciences by providing sophisticated tools and solutions to manage, analyze, and interpret complex biological data. Life science IT solutions are designed to streamline various processes within the life sciences domain, including research, drug discovery, clinical trials, and healthcare management. Life science IT software typically includes applications for data management, analysis, and visualization, facilitating the collection, storage, and interpretation of complex biological and clinical data. Life science IT solutions enable researchers to conduct experiments, analyze results, and make informed decisions in areas such as drug discovery, genomics, proteomics, and personalized medicine. Additionally, life science IT software often incorporates features for regulatory compliance, quality control, and collaboration, ensuring that organizations adhere to industry standards and best practices while fostering teamwork and knowledge sharing among multidisciplinary teams.
According to our (Global Info Research) latest study, the global Life Sciences IT market size was valued at US$ 21930 million in 2023 and is forecast to a readjusted size of USD 45170 million by 2030 with a CAGR of 10.7% during review period.
The life sciences IT market size in expected to grow significantly, owing to high demand for advance analytical tool to analyze and manage large data generated in the healthcare sector, rise in adoption of the life science IT technology in the drug discovery and development, and growing trend towards digitalization of the healthcare system. According to life sciences IT market forecast, rise in demand for advanced analytical tools is expected to act as a significant driver for the growth of the life sciences IT market. The exponential increase in the volume of data generated within healthcare, fueled by electronic health records, genomic information, and real-time patient monitoring systems, has resulted in increase in demand for sophisticated analytical solutions for efficient analysis and management. For instance, according to a 2023 report by the National Library of Medicine, over 80% of digital data in healthcare is available as unstructured data, requiring new forms of data processing and standardizing that prove challenging to health researchers.
This report is a detailed and comprehensive analysis for global Life Sciences IT market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Life Sciences IT market size and forecasts, in consumption value ($ Million), 2019-2030
Global Life Sciences IT market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Life Sciences IT market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Life Sciences IT market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Life Sciences IT
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Life Sciences IT market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Oracle Corporation, Revvity, Inc, Clario, Illumina, Inc, Qiagen NV, Agilent Technologies, Inc, IBM Corporation, Genedata AG, DNAnexus, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Life Sciences IT market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Life Sciences IT market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Software
Services
Market segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others
Market segment by players, this report covers
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Life Sciences IT product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Life Sciences IT, with revenue, gross margin, and global market share of Life Sciences IT from 2019 to 2024.
Chapter 3, the Life Sciences IT competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Life Sciences IT market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Life Sciences IT.
Chapter 13, to describe Life Sciences IT research findings and conclusion.